HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Ogasawara Selected Research

Type 2 Diabetes Mellitus (MODY)

4/2012Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Ogasawara Research Topics

Disease

4Stomach Neoplasms (Stomach Cancer)
04/2009 - 12/2006
1Weight Loss (Weight Reduction)
01/2015
1Colitis
01/2015
1Inflammation (Inflammations)
01/2015
1Neoplasm Metastasis (Metastasis)
07/2012
1Colorectal Neoplasms (Colorectal Cancer)
07/2012
1Type 2 Diabetes Mellitus (MODY)
04/2012
1Adenoma (Adenomas)
01/2007
1Carcinoma (Carcinomatosis)
01/2007
1Carcinoid Tumor (Carcinoid)
01/2007
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2006
1Adenocarcinoma
12/2006
1Dyspepsia (Indigestion)
06/2005
1Abdominal Pain (Pain, Abdominal)
06/2005
1Gastroesophageal Reflux (GERD)
06/2005
1Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
10/2004
1HPRT-Related Gout
10/2004
1Airway Obstruction (Choking)
05/2002
1Coma (Comas)
12/2001
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2001
1Communicable Diseases (Infectious Diseases)
04/2001
1Scarlet Fever
04/2001
1Septic Shock (Toxic Shock Syndrome)
04/2001
1Lung Injury
02/2001
1Asymptomatic Diseases
01/2001
1Pulmonary Emphysema
07/2000
1Neuroblastoma
05/2000
1Hyperthermia
04/2000

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
07/2012 - 04/2012
2DNA (Deoxyribonucleic Acid)IBA
07/2012 - 12/2001
2Gadolinium DTPA (Magnevist)FDA Link
05/2002 - 11/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2015
1Dextrans (Dextran)FDA Link
01/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Peroxidase (Myeloperoxidase)IBA
01/2015
1Cyclin D2IBA
04/2009
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
04/2009
1Pepsinogen A (Pepsinogen)IBA
01/2009
1Differentiation AntigensIBA
01/2009
1Chromogranin AIBA
01/2007
1beta CateninIBA
12/2006
1Omeprazole (Prilosec)FDA LinkGeneric
06/2005
1Famotidine (Pepcid)FDA LinkGeneric
06/2005
1Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
10/2004
1AerosolsIBA
05/2002
1EnbucrilateIBA
05/2002
1Phosphotransferases (Kinase)IBA
12/2001
1ExotoxinsIBA
04/2001
1Enterotoxins (Enterotoxin)IBA
04/2001
1Anti-Bacterial Agents (Antibiotics)IBA
04/2001
1SuperantigensIBA
04/2001
1Virulence Factors (Pathogenicity Factors)IBA
04/2001
1Pentetic Acid (DTPA)FDA LinkGeneric
02/2001
1Surface-Active Agents (Surfactants)IBA
02/2001
1AcidsIBA
02/2001
1Adenosine Triphosphate (ATP)IBA
01/2001
1AMP Deaminase (Myoadenylate Deaminase)IBA
01/2001
1Xenon-133IBA
07/2000
13-Iodobenzylguanidine (Iobenguane)IBA
05/2000
1Iodine-123IBA
05/2000
1Iodine-131IBA
05/2000
1CatecholaminesIBA
05/2000
1Dacarbazine (DIC)FDA LinkGeneric
04/2000

Therapy/Procedure

1Therapeutics
07/2012
1Catheters
05/2002
1Drug Therapy (Chemotherapy)
05/2000
1Aftercare (After-Treatment)
05/2000